×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: CBS/PSP Supplements Guide
therapeutic
6,929 words
KG: ent-dise-bfd8f32d
2026-03-24
section:therapeutics
kind:therapeutic
topic:psp
topic:cbs
state:published
Contents
CBS/PSP Supplements Guide
💊
Therapeutic Info
Name
CBS/PSP Supplements Guide
Summary
Comprehensive supplement evaluation and dosing guide for CBS/PSP with levodopa/rasagiline
Knowledge Graph
Related Hypotheses (16)
Microbial Inflammasome Priming Prevention
Score: 0.58
Aquaporin-4 Polarization Rescue
Score: 0.51
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
Circadian Clock-Autophagy Synchronization
Score: 0.55
Temporal Decoupling via Circadian Clock Reset
Score: 0.52
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67
SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc
Score: 0.60
Circadian-Synchronized Proteostasis Enhancement
Score: 0.58
Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromat
Score: 0.52
SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.51
Conditional CRISPR Kill Switches for Aberrant Protein Cleara
Score: 0.45
Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci
Score: 0.45
Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration
Score: 0.45
Show 11 more
Related Analyses (7)
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Show 2 more
Related Experiments (30)
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.46
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.46
Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.46
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.46
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.46
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.46
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.46
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.46
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.46
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.46
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.46
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.46
Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.46
Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.46
Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.46
Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.46
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.46
Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.46
Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.46
Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.46
Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.46
Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.46
Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.46
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.46
NPH Glymphatic System Interaction Experiment
clinical · proposed · Score: 0.46
Gandouling protection against brain injury in Wilson's disea
validation · proposed · Score: 0.90
Epigenetic Clocks in Neurodegeneration — Causal Drivers or P
validation · proposed · Score: 0.46
Show 25 more